Free Trial

Aspen Aerogels (NYSE:ASPN) Releases FY 2025 Earnings Guidance

Aspen Aerogels logo with Construction background

Key Points

  • Aspen Aerogels has provided FY 2025 earnings guidance with an EPS estimate of -3.860 to -3.730, which is below the consensus estimate of -3.260.
  • The company is projecting revenue between $297.0 million and $317.0 million, slightly higher than the consensus estimate of $296.5 million.
  • Recent analyst reports include a downgrade by Oppenheimer to "market perform" and a reduced price target from Barclays to $7.00, which reflects growing skepticism about the stock's performance.
  • Looking to Export and Analyze Aspen Aerogels Data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Aspen Aerogels (NYSE:ASPN - Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided EPS guidance of -3.860--3.730 for the period, compared to the consensus EPS estimate of -3.260. The company issued revenue guidance of $297.0 million-$317.0 million, compared to the consensus revenue estimate of $296.5 million.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the stock. Canaccord Genuity Group cut their target price on shares of Aspen Aerogels from $11.00 to $10.00 and set a "buy" rating for the company in a report on Friday. Oppenheimer lowered Aspen Aerogels from an "outperform" rating to a "market perform" rating in a research note on Thursday, May 8th. Finally, Barclays reaffirmed an "equal weight" rating and set a $7.00 target price (down from $13.00) on shares of Aspen Aerogels in a research note on Thursday, May 29th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, six have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $18.38.

Check Out Our Latest Stock Analysis on ASPN

Aspen Aerogels Stock Performance

Shares of ASPN stock traded down $0.03 during mid-day trading on Friday, hitting $7.54. 3,912,783 shares of the stock were exchanged, compared to its average volume of 2,654,134. The stock's fifty day simple moving average is $6.72 and its two-hundred day simple moving average is $7.07. The stock has a market capitalization of $619.11 million, a price-to-earnings ratio of -1.98 and a beta of 2.73. Aspen Aerogels has a 12-month low of $4.16 and a 12-month high of $33.15. The company has a debt-to-equity ratio of 0.40, a quick ratio of 3.53 and a current ratio of 4.22.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The construction company reported ($0.04) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.12) by $0.08. Aspen Aerogels had a positive return on equity of 2.66% and a negative net margin of 78.53%. The firm had revenue of $78.02 million for the quarter, compared to analyst estimates of $72.53 million. During the same quarter last year, the company posted $0.21 earnings per share. The business's revenue was down 33.8% on a year-over-year basis. On average, analysts forecast that Aspen Aerogels will post 0.17 EPS for the current year.

Insiders Place Their Bets

In other Aspen Aerogels news, CEO Donald R. Young acquired 20,000 shares of the stock in a transaction on Monday, May 12th. The shares were bought at an average price of $5.35 per share, with a total value of $107,000.00. Following the acquisition, the chief executive officer owned 550,856 shares of the company's stock, valued at $2,947,079.60. This trade represents a 3.77% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 4.30% of the company's stock.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Creative Planning purchased a new stake in shares of Aspen Aerogels during the 2nd quarter valued at $91,000. Acadian Asset Management LLC purchased a new stake in shares of Aspen Aerogels during the 1st quarter valued at $43,000. Caxton Associates LLP purchased a new stake in Aspen Aerogels during the 1st quarter worth $307,000. Goldman Sachs Group Inc. boosted its position in Aspen Aerogels by 89.7% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,274,356 shares of the construction company's stock worth $8,143,000 after purchasing an additional 602,586 shares during the period. Finally, Integrated Wealth Concepts LLC purchased a new stake in Aspen Aerogels during the 1st quarter worth $84,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Aspen Aerogels Company Profile

(Get Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Read More

Earnings History and Estimates for Aspen Aerogels (NYSE:ASPN)

Should You Invest $1,000 in Aspen Aerogels Right Now?

Before you consider Aspen Aerogels, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.

While Aspen Aerogels currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Growth Stocks That Could Pop Before Summer Ends
3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines